MedPath
NMPA Approval

Potassium Aspartate Injection

国药准字H20244775

September 3, 2024

Drug Information

门冬氨酸钾注射液

注射剂

20ml:门冬氨酸钾3.424g(按C₄H₆KNO₄ 计

化学药品

September 3, 2024

Company Information

Applicant Company

河南省孟州市谷旦镇曲村工业区

Manufacturing Company

林州市兴林路西段

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬氨酸钾注射液 - NMPA 批准文号 | MedPath